Exploiting the G2-M cell cycle checkpoint dependency in small cell lung cancer (SCLC) using pharmacological inhibitors of CHK1 and WEE1

被引：0
|
作者：
Sen, Triparna
Tong, Pan
Stewart, Catherine Allison
Cristea, Sandra
Hong-Fan, You
Glisson, Bonnie S.
Gibbons, Don L.
Sage, Julien
Wang, Jing
Byers, Lauren A.
机构：
来源：
MOLECULAR CANCER RESEARCH | 2016年 / 14卷
关键词：
D O I：
10.1158/1557-3125.CELLCYCLE16-PR10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR10
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up-regulation
    Zhao, Xiaoliang
    Kim, In-Kyu
    Kallakury, Bhaskar
    Chahine, Joeffrey J.
    Iwama, Eiji
    Pierobon, Mariaelena
    Petricoin, Emanuel
    McCutcheon, Justine N.
    Zhang, Yu-Wen
    Umemura, Shigeki
    Chen, Vincent
    Wang, Changli
    Giaccone, Giuseppe
    MOLECULAR ONCOLOGY, 2021, 15 (04) : 1130 - 1145
  • [2] INCREASING TUMOR TREATING FIELDS (TTFIELDS) EFFICACY BY TARGETING THE G2 CELL CYCLE CHECKPOINT WITH WEE1 OR CHK1 INHIBITORS IN GLIOBLASTOMA CELL LINES
    Slangen, Paul L. G.
    de Gooijer, Mark C.
    van Geldorp, Mariska
    van Tellingen, Olaf
    Borst, Gerben R.
    NEURO-ONCOLOGY, 2020, 22 : 93 - 93
  • [3] Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells
    Vera, Julio
    Raatz, Yvonne
    Wolkenhauer, Olaf
    Kottek, Tina
    Bhattacharya, Animesh
    Simon, Jan C.
    Kunz, Manfred
    CELLULAR SIGNALLING, 2015, 27 (05) : 951 - 960
  • [4] Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor-resistant cancer
    Gupta, Nitasha
    Huang, Tzu-Ting
    Horibata, Sachi
    Lee, Jung-Min
    PHARMACOLOGICAL RESEARCH, 2022, 178
  • [5] ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells
    Ronco, Cyril
    Martin, Anthony R.
    Demange, Luc
    Benhida, Rachid
    MEDCHEMCOMM, 2017, 8 (02) : 295 - 319
  • [6] ATR-Chk1-Wee1 pathway controls melanoma cell cycle in G2-M and G0-G1
    Vera, J.
    Raatz, Y.
    Kottek, T.
    Bhattacharya, A.
    Simon, J. C.
    Kunz, M.
    EXPERIMENTAL DERMATOLOGY, 2015, 24 (03) : E33 - E33
  • [7] Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma
    Gry Irene Magnussen
    Elisabeth Emilsen
    Karianne Giller Fleten
    Birgit Engesæter
    Viola Nähse-Kumpf
    Roar Fjær
    Ana Slipicevic
    Vivi Ann Flørenes
    BMC Cancer, 15
  • [8] The critical role of CDK2 activation in determining the differential sensitivity of cell lines to Chk1 and Wee1 inhibitors
    Sakurikar, Nandini
    Thompson, Ruth
    Montano, Ryan
    Eastman, Alan
    CANCER RESEARCH, 2015, 75
  • [9] Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma
    Magnussen, Gry Irene
    Emilsen, Elisabeth
    Fleten, Karianne Giller
    Engesaeter, Birgit
    Nahse-Kumpf, Viola
    Fjaer, Roar
    Slipicevic, Ana
    Florenes, Vivi Ann
    BMC CANCER, 2015, 15
  • [10] CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cells
    Grabauskiene, Svetlana
    Bergeron, Edward J.
    Chen, Guoan
    Chang, Andrew C.
    Lin, Jules
    Thomas, Dafydd G.
    Giordano, Thomas J.
    Beer, David G.
    Morgan, Meredith A.
    Reddy, Rishindra M.
    LUNG CANCER, 2013, 82 (03) : 477 - 484
12345